Dosing
Where to inject tirzepatide: approved sites and technique
The best site is an approved location where you can follow the device instructions reliably. Mounjaro and Zepbound list the abdomen, thigh, and upper arm for subcutaneous injection.
Choosing among approved locations
The abdomen, thigh, and upper arm are labeled injection locations. Choose a site you can safely reach and inspect. An upper-arm injection may require another person's help depending on the device and technique. Follow the supplied Instructions for Use for the exact placement and any required distance from the navel.
Do not inject into a vein or muscle, use an irritated or damaged area, or choose a site because a social-media anecdote promises stronger appetite suppression. The labels allow the approved sites; they do not direct everyone to the abdomen for better weight loss.
Sources: Mounjaro prescribing information · Zepbound prescribing information
Rotate spots and keep the routine clear
Rotation means choosing a different spot, even if you continue using the same general body area. Record the day and location if that helps prevent repeating the same spot or accidentally taking an extra dose.
If you also inject insulin, keep the injections separate and follow both medicines' instructions. Do not mix medicines together. Sharing a multidose pen is unsafe even if a new needle is used. Check the solution and product condition according to the device guidance before use.
Sources: Mounjaro prescribing information · Zepbound prescribing information
Check the exact product and device
Weekly semaglutide and tirzepatide medicines are injected under the skin, not into a vein or muscle. Approved pens, prefilled syringes, and vials have presentation-specific Instructions for Use. The supplied device determines preparation, injection steps, and what to do if delivery is uncertain.
A compounded vial needs pharmacy-specific concentration and syringe instructions. Milligrams, milliliters, and syringe units are different measures. Do not copy a branded pen technique or another patient's syringe markings. Ask for training whenever the product or presentation changes.
Sources: Wegovy prescribing information, including tablets and Wegovy HD · Ozempic prescribing information · Mounjaro prescribing information · Zepbound prescribing information · FDA concerns with unapproved GLP-1 drugs used for weight loss
When technique or delivery is uncertain
If liquid leaks, a device malfunctions, or you cannot tell whether the full dose was delivered, ask the pharmacist or prescriber how to proceed. Repeating a dose without guidance can create an overdose risk. Keep the device and packaging information available for the conversation.
Changing the site does not substitute for care when nausea, abdominal pain, or other symptoms persist. Report significant skin reactions, severe pain, or infection concerns. A clinician can review the injection technique and the symptoms separately.
Sources: Mounjaro prescribing information · Zepbound prescribing information
A site diagram is only part of the technique
Mounjaro and Zepbound may be supplied in different presentations. A single-dose device, a multidose pen, and a vial involve different preparation and administration tasks even though the approved general body locations overlap. Ask the pharmacist to teach the exact device rather than copying a video about a similarly named product from another country or an older presentation.
Choose a permitted area you can inspect and reach without rushing. If the upper arm is difficult to manage, discuss assistance or another labeled location. Check the medicine and equipment as the Instructions for Use direct. A vial also requires the specified syringe and a clear volume instruction. The phrase "inject into the thigh" is incomplete if the patient does not know how to prepare or measure the prescribed dose.
Sources: Mounjaro prescribing information · Zepbound prescribing information
Build a repeatable injection routine
Set aside the labeled product, any required supplies, instructions, and dose log before beginning. Confirm the weekly date and that no one has already given the dose. Select a new exact spot within a permitted area, and use the preparation and completion steps for the supplied device. Record the injection afterward and arrange safe disposal of used sharps.
If insulin is also prescribed, keep its injection separate and follow both sets of directions. Do not mix medicines to reduce the number of injections. Pens must not be shared. If another person helps, make completion visible in one shared record to avoid duplicate treatment. These habits improve clarity, but they do not replace a pharmacist demonstration when the presentation changes or when you are unsure how a dose is delivered.
Sources: Mounjaro prescribing information · Zepbound prescribing information
When a site question becomes a clinical question
A local skin problem and a systemic adverse effect need different assessments. Increasing pain or an unusual reaction at the injection site deserves review. Persistent vomiting, diarrhea, or severe abdominal pain cannot be assumed to come from choosing the wrong body area. Tirzepatide's gastrointestinal and dehydration warnings remain relevant at every labeled site.
If the device malfunctions or delivery is uncertain, do not repeat the injection based on how much liquid appears to have leaked. Contact the pharmacist or prescriber with the product, strength, device details, and time of the attempt. A confirmed missed dose has a labeled timing rule; an uncertain partial delivery is a different situation. Also avoid assuming that changing sites removes oral contraceptive precautions or other medicine interactions, which concern the medicine's effects after administration.
Sources: Mounjaro prescribing information · Zepbound prescribing information
Sources and evidence
Sources checked October 2, 2026. Prescribing information supports medication facts; provider pages support advertised services. Offers and labels can change.